SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Sphingosine kinase 1 (SphK1) is overexpressed in skin squamous cell carcinoma (SCC) and represents a potential therapeutic target.
• MicroRNAs play crucial roles in regulating gene expression and are implicated in various cancers.

Purpose of the Study:

• To identify and characterize novel microRNAs targeting SphK1 in skin SCC.
• To investigate the functional role of microRNA-6784 (miR-6784) in regulating SphK1 expression and its impact on skin SCC progression.

Main Methods:

• Identification of miR-6784 as a SphK1-targeting microRNA.
• Luciferase reporter assays to confirm direct binding of miR-6784 to the SphK1 3'-UTR.
• Overexpression and silencing studies of miR-6784 in A431 and SCC9 cell lines.
• Assessment of cell viability, proliferation, migration, invasion, and apoptosis.
• SphK1 knockout using CRISPR/Cas9 technology.

Main Results:

• miR-6784 directly binds to the 3'-UTR of SphK1 mRNA, inhibiting its expression and leading to ceramide accumulation.
• Overexpression of miR-6784 significantly inhibited skin SCC cell viability, proliferation, migration, and invasion, while inducing apoptosis.
• Silencing miR-6784 using antagomiR-6784 increased SphK1 levels and promoted SCC cell proliferation, migration, and invasion.
• The anti-tumor effects of miR-6784 were dependent on SphK1 expression, as demonstrated by experiments with UTR-null SphK1 constructs and SphK1 knockout cells.

Conclusions:

• miR-6784 functions as a tumor suppressor in skin SCC by directly targeting and downregulating SphK1.
• miR-6784 holds potential as a novel therapeutic agent for skin squamous cell carcinoma.